SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Viktor V Chirikov, Fadia T Shaya, Charles D Howell, Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C, Expert Review of Gastroenterology & Hepatology, 2014, 8, 8, 973

    CrossRef

  2. 2
    Paulino Tallón de Lara, Thomas Himschoot, Jean-Louis Frossard, Francesco Negro, Does telaprevir possess a direct antidiabetic effect?, Liver International, 2014, 34, 6
  3. 3
    Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego, Extrahepatic manifestations of chronic hepatitis C virus infection, Digestive and Liver Disease, 2014, 46, S165

    CrossRef

  4. 4
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  5. 5
    Linda Henry, Zobair Younossi, Hepatitis: Chronic HCV infection, diabetes and liver-related outcomes, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 9, 520

    CrossRef

  6. 6
    Yuji Urabe, Hidenori Ochi, Naoya Kato, Vinod Kumar, Atsushi Takahashi, Ryosuke Muroyama, Naoya Hosono, Motoyuki Otsuka, Ryosuke Tateishi, Paulisally Hau Yi Lo, Chizu Tanikawa, Masao Omata, Kazuhiko Koike, Daiki Miki, Hiromi Abe, Naoyuki Kamatani, Joji Toyota, Hiromitsu Kumada, Michiaki Kubo, Kazuaki Chayama, Yusuke Nakamura, Koichi Matsuda, A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region, Journal of Hepatology, 2013, 58, 5, 875

    CrossRef

  7. 7
    Zobair Younossi, Francesco Negro, Lawrence Serfaty, Stanislas Pol, Moises Diago, Stefan Zeuzem, Pietro Andreone, Eric J. Lawitz, Stuart Roberts, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Bruce Coate, Ralph DeMasi, Gaston Picchio, James Witek, Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial, Hepatology, 2013, 58, 6
  8. 8
    Alessandra Mangia, Maria Ripoli, Insulin resistance, steatosis and hepatitis C virus, Hepatology International, 2013, 7, S2, 782

    CrossRef

  9. 9
    Elisabetta Degasperi, Mauro Viganò, Alessio Aghemo, Pietro Lampertico, Massimo Colombo, PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history, Expert Review of Anti-infective Therapy, 2013, 11, 5, 459

    CrossRef

  10. 10
    Alessio Aghemo, Pietro Lampertico, Massimo Colombo, Assessing long-term treatment efficacy in chronic hepatitis B and C: Between evidence and common sense, Journal of Hepatology, 2012, 57, 6, 1326

    CrossRef